SCHEMBL6710325

SCHEMBL6710325

O=C(Cc1ccc(F)cc1)Nc1cccc2cc(C(=O)Nc3ccc(Cl)cc3-c3noc(=O)[nH]3)[nH]c12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXFP1 Q9HBX9 2/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
GRIK1 P39086 1/20 0.40
PARP14 Q460N5 1/20 0.39
CASP3 P42574 1/20 0.38
MAPT P10636 2/20 0.38
TP53 P04637 1/20 0.38
POLB P06746 1/20 0.38
PLCG2 P16885 1/20 0.38
HDAC3 O15379 2/20 0.37
HDAC1 Q13547 2/20 0.37
HDAC2 Q92769 2/20 0.37
NCOR2 Q9Y618 2/20 0.37
CCNA2 P20248 1/20 0.37
CDK2 P24941 1/20 0.37
PLA2G7 Q13093 4/20 0.37
NHERF1 O14745 1/20 0.35
PYGL P06737 1/20 0.35
KCNMA1 Q12791 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6713394 0.95 PARP14 (0.42) MEN1KMT2AGRIK1PARP14MAPT
SCHEMBL6707881 0.93 PARP14 (0.42) RXFP1MEN1KMT2AGRIK1PARP14
SCHEMBL6709861 0.93 GRIK1 (0.41) MEN1KMT2AGRIK1PARP14TP53
SCHEMBL6712250 0.92 P2RY14 (0.41) RXFP1GRIK1PARP14MAPTTP53
SCHEMBL6707991 0.92 PTK2B (0.41) MEN1KMT2AGRIK1PARP14MAPT
SCHEMBL6708772 0.92 PARP14 (0.42) RXFP1MEN1KMT2AGRIK1PARP14
SCHEMBL6708770 0.91 GRIK1 (0.41) MEN1KMT2AGRIK1PARP14POLB
SCHEMBL6711858 0.91 PTK2B (0.39) GRIK1PARP14MAPTTP53PLCG2
SCHEMBL6712528 0.91 GRIK1 (0.39) GRIK1PARP14MAPTTP53PLCG2
SCHEMBL6711895 0.91 PARP14 (0.44) MEN1KMT2AGRIK1PARP14MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 RXFP1 3836/4885MEN1 4100/4885KMT2A 3181/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.